MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2026 AND SCHEDULES NOVEMBER 23, 2026 CONFERENCE CALL
November 19, 2026
Our vision is to become a leading pharmaceutical company within the U.S., offering a growing portfolio of products that improve patients' lives.
At Medicure, we are focused on improving the health of patients by offering a growing portfolio of products and services and ensuring all patients get access to care they need.
A Conference call will be held Monday, November 23, 2026 at 8:30 AM Eastern Time (8:30 AM Manitoba Time)
At Medicure, our mission is to serve patients by delivering safe and efficacious life-changing medicines
Medicure's Phase 3 clinical trial aims to evaluate the use of its investigational product MC-1 for treatment of a rare pediatric disease called pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency.
Medicure Inc.– via Marley Drug, creates a direct-to-consumer e-commerce pharmacy solution. The service is available in all 50 states and can fulfill a formulary of over 100 prescription medications.
Copyright © 2026 Medicure Inc. All Rights Reserved. | Privacy Policy | Your Privacy Choices | Cookie Preferences